药明生物(02269)因期权获行使而发行合计605万股

Core Viewpoint - WuXi Biologics (02269) announced the issuance of a total of 6.05 million ordinary shares on November 25, 2025, as part of its pre-IPO share option plan adopted on January 5, 2016, and revised on August 10, 2016 [1] Group 1 - The company will issue 6.05 million ordinary shares [1]